Researchers review data using insects as a sustainable and environmentally friendly source of protein, vitamins, and minerals.
Novartis pays $1B upfront for PTC’s Phase 2 Huntington’s drug
Novartis is returning to Huntington’s disease with a $1 billion upfront bet, plus another $1.9 billion in biobucks, for access to a Phase 2 oral